Optimisation of a triazolopyridine based histone demethylase inhibitor yields a potent and selective KDM2A (FBXL11) inhibitor. (2014)
Attributed to:
EPSRC-Royal Society fellowship engagement (2012): Development of Chemical Tools for Probing Histone Demethylases
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1039/c4md00291a
PubMed Identifier: 26682034
Publication URI: http://europepmc.org/abstract/MED/26682034
Type: Journal Article/Review
Volume: 5
Parent Publication: MedChemComm
Issue: 12
ISSN: 2040-2503